{"id":36714,"date":"2015-09-09T08:31:01","date_gmt":"2015-09-09T12:31:01","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36714"},"modified":"2015-09-09T08:31:01","modified_gmt":"2015-09-09T12:31:01","slug":"pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714","title":{"rendered":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Pharmacyte Biotech Inc (OTCMKTS:PMCB)<\/strong> <a href=\"http:\/\/finance.yahoo.com\/news\/pharmacyte-biotech-announces-successful-completion-133850506.html\">stated<\/a> that it has completed the interim audit of cGMP facility. The company will acquire the cell-in-a-box capsules for the clinical trials from the same facility. Austrianova\u2019s Chief Technical Officer, Professor Walter H. G\u00fcnzburg, stated that they are pleased to report that there were no major issues during the inspection process.<\/p>\n<p style=\"text-align: justify;\">The company will now carry out the \u201cshake-down\u201d runs at the cGMP facility. These tests are needed before the facility can commence production work of the three consecutive runs that will be utilized to validate compliance of the process as per cGMP standards.<\/p>\n<p style=\"text-align: justify;\">In the last trading session, the share price of Pharmacyte plunged over 5% to close the day at $.0910.<\/p>\n<p style=\"text-align: justify;\"><strong>Nutra Pharma Corp. (OTCMKTS:NPHC) Obtains Orphan Drug Status For RPI-78M <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Nutra Pharma Corp. (OTCMKTS:NPHC)<\/strong> <a href=\"http:\/\/money.cnn.com\/news\/newsfeeds\/articles\/marketwire\/1215972.htm\">reported<\/a> that they have obtained Orphan Drug status from the FDA for its drug candidate RPI-78M for the cure of Multiple Sclerosis in children. Rik J. Deitsch, the CEO and Chairman, said that obtaining orphan drug status by the U.S. FDA is a considerable milestone for the company. Multiple Sclerosis in children is an important disease segment that as of now is not being treated by other drug candidates in the market.<\/p>\n<p style=\"text-align: justify;\">Based on open label trials and pre-clinical trials using RPI-78M, the management believes that drug has the ability to get through the approval process. Now, they intend to prepare an Investigative NDA with the FDA and advance the clinical trial protocols required for drug approval.<\/p>\n<p style=\"text-align: justify;\"><strong>Growblox Sciences Inc (OTCMKTS:GBLX) Appoints Sandra Tiffany as New General Manager<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Growblox Sciences Inc (OTCMKTS:GBLX)<\/strong> <a href=\"http:\/\/finance.yahoo.com\/news\/growblox-sciences-appoints-former-nevada-130000822.html\">reported<\/a> that they have appointed Sandra Tiffany as new General Manager. Ms. Tiffany has served as a Nevada State Senator for as much as 14 years. During this period, she served on various leadership roles and authored &#8220;game changing&#8221; legislation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmacyte Biotech Inc (OTCMKTS:PMCB) stated that it has completed the interim audit of cGMP facility. The company will acquire the cell-in-a-box capsules for the clinical [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":32925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[11676,6989,11651,11650,6990,11652,11643,11642,11641],"stock_ticker":[],"class_list":["post-36714","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-growblox-sciences-inc","tag-growblox-sciences-inc-otcmktsgblx","tag-nutra-pharma-corp","tag-nutra-pharma-corp-otcmktsnphc","tag-otcmktsgblx","tag-otcmktsnphc","tag-otcmktspmcb","tag-pharmacyte-biotech-inc","tag-pharmacyte-biotech-inc-otcmktspmcb","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) stated that it has completed the interim audit of cGMP facility. The company will acquire the cell-in-a-box capsules for the clinical [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-09T12:31:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility\",\"datePublished\":\"2015-09-09T12:31:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714\"},\"wordCount\":324,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"keywords\":[\"Growblox Sciences Inc\",\"Growblox Sciences Inc. (OTCMKTS:GBLX)\",\"Nutra Pharma Corp.\",\"Nutra Pharma Corp. (OTCMKTS:NPHC)\",\"OTCMKTS:GBLX\",\"OTCMKTS:NPHC\",\"OTCMKTS:PMCB\",\"Pharmacyte Biotech Inc\",\"Pharmacyte Biotech Inc (OTCMKTS:PMCB)\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714\",\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"datePublished\":\"2015-09-09T12:31:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714","og_locale":"en_US","og_type":"article","og_title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility - Wall Street PR","og_description":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) stated that it has completed the interim audit of cGMP facility. The company will acquire the cell-in-a-box capsules for the clinical [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-09-09T12:31:01+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility","datePublished":"2015-09-09T12:31:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714"},"wordCount":324,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","keywords":["Growblox Sciences Inc","Growblox Sciences Inc. (OTCMKTS:GBLX)","Nutra Pharma Corp.","Nutra Pharma Corp. (OTCMKTS:NPHC)","OTCMKTS:GBLX","OTCMKTS:NPHC","OTCMKTS:PMCB","Pharmacyte Biotech Inc","Pharmacyte Biotech Inc (OTCMKTS:PMCB)"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714","name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","datePublished":"2015-09-09T12:31:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-updates-on-interim-audit-completion-of-cgmp-facility-36714#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) Updates On Interim Audit Completion Of cGMP Facility"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36714"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36714\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/32925"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36714"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}